Variant report
Variant | nsv820117 |
---|---|
Chromosome Location | chr12:43019570-43027481 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:43025345-43025677 | IMR90 | lung: | n/a | n/a |
2 | CEBPB | chr12:43025330-43025600 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr12:43025322-43025688 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr12:43025444-43025655 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr12:43025359-43025674 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CHD2 | chr12:43019491-43019597 | K562 | blood: | n/a | n/a |
7 | EP300 | chr12:43024204-43024416 | K562 | blood: | n/a | n/a |
8 | EP300 | chr12:43025398-43025636 | Hela-S3 | cervix: | n/a | n/a |
9 | KAP1 | chr12:43023782-43024522 | U2OS | brain: | n/a | n/a |
10 | KAP1 | chr12:43023607-43024511 | HEK293 | kidney: | n/a | n/a |
11 | MAZ | chr12:43027324-43027341 | HepG2 | liver: | n/a | n/a |
12 | NFIC | chr12:43019321-43019865 | ECC-1 | luminal epithelium: | n/a | n/a |
13 | NFYA | chr12:43019481-43019684 | Hela-S3 | cervix: | n/a | chr12:43019530-43019548 chr12:43019554-43019572 |
14 | NFYA | chr12:43019379-43019678 | K562 | blood: | n/a | chr12:43019530-43019548 chr12:43019554-43019572 |
15 | NFYB | chr12:43019303-43019703 | K562 | blood: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
16 | NFYB | chr12:43019379-43019617 | GM12878 | blood: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
17 | NFYB | chr12:43019394-43019613 | Hela-S3 | cervix: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
18 | POLR2A | chr12:43023525-43023576 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr12:43026076-43026105 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr12:43023607-43023620 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | PRDM1 | chr12:43025419-43025709 | Hela-S3 | cervix: | n/a | chr12:43025547-43025561 chr12:43025548-43025561 chr12:43025548-43025557 chr12:43025464-43025479 |
22 | RCOR1 | chr12:43024116-43024461 | K562 | blood: | n/a | n/a |
23 | SETDB1 | chr12:43023947-43024926 | U2OS | brain: | n/a | n/a |
24 | SPI1 | chr12:43025453-43025798 | HL-60 | blood: | n/a | n/a |
25 | STAT3 | chr12:43025541-43025741 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | TAL1 | chr12:43024297-43024443 | K562 | blood: | n/a | n/a |
27 | TCF7L2 | chr12:43023886-43024538 | HEK293 | kidney: | n/a | n/a |
28 | TEAD4 | chr12:43024071-43024481 | K562 | blood: | n/a | n/a |
29 | ZNF384 | chr12:43024570-43024588 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PRICKLE1-1 | chr12:43023263-43023488 | ENSG00000257510 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257687 | TF binding region |
ENSG00000257405 | chromatin interactions |
POGZ | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12424138 | chr12:43019593-43019594 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs151020738 | chr12:43019595-43019596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs56836086 | chr12:43019607-43019608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs397975480 | chr12:43019609-43019610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536227354 | chr12:43019617-43019618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182679284 | chr12:43019686-43019687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113032841 | chr12:43019755-43019756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7977195 | chr12:43019780-43019781 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs12426988 | chr12:43019781-43019782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs557852588 | chr12:43019799-43019800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186629590 | chr12:43019828-43019829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12424455 | chr12:43019872-43019873 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs144720281 | chr12:43019984-43019985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370167943 | chr12:43019995-43019996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143607649 | chr12:43020076-43020077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10880332 | chr12:43020166-43020167 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs148047695 | chr12:43020167-43020168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79604310 | chr12:43020234-43020235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545909287 | chr12:43020244-43020245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140881070 | chr12:43020274-43020275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531490403 | chr12:43020275-43020276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150303009 | chr12:43020430-43020431 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs386762533 | chr12:43020444-43020445 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs77568420 | chr12:43020451-43020452 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs538738817 | chr12:43020470-43020471 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs150203082 | chr12:43020524-43020525 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs191481631 | chr12:43020533-43020534 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs184793404 | chr12:43020549-43020550 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs547404930 | chr12:43020560-43020561 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs566525469 | chr12:43020612-43020613 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs78474830 | chr12:43020619-43020620 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs7313926 | chr12:43020633-43020634 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs139018072 | chr12:43020666-43020667 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs538026362 | chr12:43020670-43020671 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs79127723 | chr12:43020705-43020706 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs113689305 | chr12:43020709-43020710 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs536122370 | chr12:43020732-43020733 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs143136972 | chr12:43020789-43020790 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs17091505 | chr12:43020797-43020798 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs202197719 | chr12:43020805-43020806 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs147475403 | chr12:43020812-43020813 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs12322671 | chr12:43020819-43020820 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs373992491 | chr12:43020825-43020826 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs7302424 | chr12:43020849-43020850 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs189167570 | chr12:43020856-43020857 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs192872508 | chr12:43020857-43020858 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs7131974 | chr12:43020864-43020865 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs118070832 | chr12:43020879-43020880 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs80034683 | chr12:43020889-43020890 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs527632703 | chr12:43020915-43020916 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:43017000-43020800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr12:43020800-43021000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr12:43020800-43021200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr12:43021000-43021800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr12:43021400-43022000 | Enhancers | Fetal Stomach | stomach |
6 | chr12:43024400-43026200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr12:43024800-43026000 | Enhancers | Primary monocytes fromperipheralblood | blood |
8 | chr12:43025000-43026000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr12:43025200-43025600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr12:43025200-43026000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr12:43025200-43026600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr12:43025600-43026000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr12:43025600-43029400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr12:43025800-43026200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr12:43026000-43029400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |